Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; FlowSight Imaging Flow cytometer; ImageStream System; CellStream Flow Cytometer; Guava easyCyte line; and Muse Cell Analyzer. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; SYNCT data management software solutions; TDAS, an analysis program designed for development and optimization of nucleic acid assays; IDEAS, an image analysis software; and xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism. In addition, it offers MultiCode assays and products comprising HSV 1&2 assays, and other products to detect infectious agents in clinical samples; ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 assays, ARIES FLU A/B and RSV assays, ARIES group A strep assays, ARIES bordetella assays, ARIES GBS assay, and ARIES C. difficile assays; and VERIGENE test cartridges. The company serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is based in Austin, Texas. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
CURRIE HARRISS T | SVP, Finance & CFO | Mar 01 | Option Exercise | 18.26 | 5,325 | 97,235 | 231,142 | Mar 01 04:31 PM | CURRIE HARRISS T | SVP, Finance & CFO | Mar 01 | Sale | 32.35 | 5,325 | 172,262 | 226,868 | Mar 01 04:31 PM | Bennett Todd C. | SVP, Global Sales & Cust Ops | Feb 25 | Option Exercise | 19.09 | 121,507 | 2,319,018 | 155,640 | Mar 01 04:33 PM | Bennett Todd C. | SVP, Global Sales & Cust Ops | Feb 25 | Sale | 34.06 | 121,507 | 4,138,088 | 34,197 | Mar 01 04:33 PM | Eck Stephen L. | Director | Nov 25 | Buy | 22.40 | 4,487 | 100,501 | 37,807 | Nov 30 11:26 AM | Rew Richard W. II | SVP, Gen Counsel & Corp Secy | Aug 05 | Option Exercise | 15.93 | 11,176 | 178,034 | 44,329 | Aug 05 06:55 PM | SHAMIR NACHUM | President & CEO | Aug 05 | Option Exercise | 15.93 | 8,559 | 136,345 | 197,583 | Aug 05 06:56 PM | Shapiro Eric | SR VP, GLOBAL MARKETING | Aug 05 | Option Exercise | 16.74 | 14,179 | 237,356 | 48,046 | Aug 06 09:24 AM | Shapiro Eric | SR VP, GLOBAL MARKETING | Aug 05 | Sale | 40.16 | 14,179 | 569,429 | 33,867 | Aug 06 09:24 AM | Fairchild Nancy | SVP, Human Resources | Aug 05 | Sale | 40.16 | 24,283 | 975,205 | 33,828 | Aug 06 09:22 AM | SHAMIR NACHUM | President & CEO | Aug 05 | Sale | 40.16 | 8,559 | 343,729 | 189,632 | Aug 05 06:56 PM | Rew Richard W. II | SVP, Gen Counsel & Corp Secy | Aug 05 | Sale | 40.93 | 11,176 | 457,434 | 33,153 | Aug 05 06:55 PM | Rew Richard W. II | SVP, Gen Counsel & Corp Secy | Aug 04 | Option Exercise | 15.93 | 3,786 | 60,311 | 36,939 | Aug 05 06:55 PM | SHAMIR NACHUM | President & CEO | Aug 04 | Option Exercise | 15.93 | 116,441 | 1,854,905 | 305,465 | Aug 05 06:56 PM | LOEWENBAUM G WALTER II | Director | Aug 04 | Sale | 39.02 | 50,000 | 1,951,030 | 450,441 | Aug 06 01:08 PM | SHAMIR NACHUM | President & CEO | Aug 04 | Sale | 39.50 | 116,441 | 4,599,420 | 189,024 | Aug 05 06:56 PM | Rew Richard W. II | SVP, Gen Counsel & Corp Secy | Aug 04 | Sale | 38.93 | 3,786 | 147,389 | 33,153 | Aug 05 06:55 PM | Rew Richard W. II | SVP, Gen Counsel & Corp Secy | Aug 03 | Option Exercise | 15.93 | 7,389 | 117,707 | 40,542 | Aug 05 06:55 PM | SHAMIR NACHUM | President & CEO | Aug 03 | Option Exercise | 15.93 | 125,000 | 1,991,250 | 314,024 | Aug 05 06:56 PM | SHAMIR NACHUM | President & CEO | Aug 03 | Sale | 38.51 | 125,000 | 4,813,138 | 189,024 | Aug 05 06:56 PM | Rew Richard W. II | SVP, Gen Counsel & Corp Secy | Aug 03 | Sale | 38.93 | 7,389 | 287,654 | 33,153 | Aug 05 06:55 PM | Fairchild Nancy | SVP, Human Resources | Jul 21 | Option Exercise | 18.54 | 69,282 | 1,284,299 | 95,786 | Jul 21 06:48 PM | Fairchild Nancy | SVP, Human Resources | Jul 21 | Sale | 37.85 | 69,282 | 2,622,324 | 58,111 | Jul 21 06:48 PM | Rew Richard W. II | SVP, Gen Counsel & Corp Secy | Jul 17 | Option Exercise | 15.93 | 11,175 | 178,018 | 43,984 | Jul 17 09:02 PM | Myers Randall | SVP, Global Mfg and Quality | Jul 17 | Option Exercise | 20.02 | 41,200 | 824,773 | 52,359 | Jul 20 08:14 PM | Fairchild Nancy | SVP, Human Resources | Jul 17 | Option Exercise | 19.13 | 50 | 957 | 58,161 | Jul 20 08:13 PM | Collins Charles J. | SR VP, R&D - US | Jul 17 | Option Exercise | 18.64 | 22,748 | 423,917 | 47,897 | Jul 20 08:13 PM | Collins Charles J. | SR VP, R&D - US | Jul 17 | Sale | 37.00 | 22,748 | 841,676 | 34,554 | Jul 20 08:13 PM | Fairchild Nancy | SVP, Human Resources | Jul 17 | Sale | 37.85 | 50 | 1,893 | 58,111 | Jul 20 08:13 PM | Myers Randall | SVP, Global Mfg and Quality | Jul 17 | Sale | 37.50 | 41,200 | 1,545,000 | 33,588 | Jul 20 08:14 PM | Rew Richard W. II | SVP, Gen Counsel & Corp Secy | Jul 17 | Sale | 36.93 | 11,175 | 412,693 | 33,153 | Jul 17 09:02 PM | Fairchild Nancy | SVP, Human Resources | Jul 15 | Option Exercise | 17.11 | 56,525 | 967,145 | 90,264 | Jul 17 10:52 AM | Collins Charles J. | SR VP, R&D - US | Jul 15 | Option Exercise | 15.93 | 37,252 | 593,424 | 71,462 | Jul 17 10:52 AM | LOEWENBAUM G WALTER II | Director | Jul 15 | Sale | 34.96 | 50,000 | 1,748,010 | 709,415 | Jul 17 10:52 AM | LOEWENBAUM G WALTER II | Director | Jul 15 | Sale | 35.90 | 50,000 | 1,794,915 | 500,441 | Jul 17 10:52 AM | Collins Charles J. | SR VP, R&D - US | Jul 15 | Sale | 34.50 | 37,252 | 1,285,298 | 34,554 | Jul 17 10:52 AM | Fairchild Nancy | SVP, Human Resources | Jul 15 | Sale | 36.01 | 56,525 | 2,035,240 | 58,111 | Jul 17 10:52 AM | Fairchild Nancy | SVP, Human Resources | Jul 06 | Option Exercise | 16.42 | 23,475 | 385,494 | 77,424 | Jul 07 10:46 AM | Fairchild Nancy | SVP, Human Resources | Jul 06 | Sale | 33.00 | 23,475 | 774,675 | 57,424 | Jul 07 10:46 AM | LOEWENBAUM G WALTER II | Director | Jul 06 | Sale | 33.00 | 26,347 | 869,382 | 759,415 | Jul 07 05:38 PM | LOEWENBAUM G WALTER II | Director | Jul 02 | Sale | 32.86 | 15,800 | 519,152 | 785,762 | Jul 06 08:17 AM | LOEWENBAUM G WALTER II | Director | Jul 01 | Sale | 32.88 | 7,853 | 258,244 | 801,562 | Jul 06 08:17 AM | LOEWENBAUM G WALTER II | Director | Jun 05 | Sale | 30.69 | 44,495 | 1,365,600 | 809,415 | Jun 05 10:59 AM | LOEWENBAUM G WALTER II | Director | Jun 04 | Sale | 31.02 | 55,505 | 1,721,798 | 853,910 | Jun 05 10:59 AM | Myers Randall | SVP, Global Mfg and Quality | May 26 | Option Exercise | 18.11 | 75,000 | 1,358,162 | 77,543 | May 27 09:53 AM | Myers Randall | SVP, Global Mfg and Quality | May 26 | Sale | 31.05 | 75,000 | 2,328,600 | 33,588 | May 27 09:53 AM | LOEWENBAUM G WALTER II | Director | May 22 | Sale | 31.27 | 86,657 | 2,709,756 | 543,460 | May 26 11:51 AM | SHAMIR NACHUM | President & CEO | Apr 16 | Option Exercise | 21.10 | 125,000 | 2,637,500 | 314,024 | Apr 16 11:26 AM | SHAMIR NACHUM | President & CEO | Apr 16 | Sale | 31.00 | 125,000 | 3,875,000 | 189,024 | Apr 16 11:26 AM | SHAMIR NACHUM | President & CEO | Apr 15 | Option Exercise | 21.10 | 79,092 | 1,668,841 | 268,116 | Apr 16 11:26 AM | SHAMIR NACHUM | President & CEO | Apr 15 | Sale | 30.00 | 79,092 | 2,372,760 | 189,024 | Apr 16 11:26 AM | SHAMIR NACHUM | President & CEO | Apr 14 | Option Exercise | 21.10 | 45,908 | 968,659 | 234,932 | Apr 16 11:26 AM | SHAMIR NACHUM | President & CEO | Apr 14 | Sale | 30.00 | 45,908 | 1,377,240 | 189,024 | Apr 16 11:26 AM | CURRIE HARRISS T | SVP, Finance & CFO | Mar 09 | Option Exercise | 16.55 | 11,217 | 185,641 | 222,913 | Mar 10 05:09 PM |
|